UCB Pharma looks to expand its epilepsy drug as Biogen cuts a deal to protect Tecfidera, while insiders suggest that pharmacists should play a bigger role in managing the growing Alzheimer's dementia population.
The medical community questions whether mobile stroke units are sustainable, new research further links concussions with Alzheimer's disease, and a new trial examines the effects of fasting on MS.
Happy New Year! Reflect on some of 2016's greatest neurological advances and look forward as institutions like the NIH take on a focused effort to explore new drugs for rare disease, the developing brain, and more.
The FDA has delayed the decision on ocrelizumab after manufacturing issues arise, while it gives the thumbs up to an investigational treatment for complex regional pain syndrome.
The NCAA honored the man and ALS patient behind the viral ALS Ice Bucket Challenge, while the UK approved mitochondrial replacement reproductive assistance and Bristol-Myers Squibb faces a $20 million fine for promoting off-label uses of its antipsychotic Abilify.
The Handoff: Your Week in Neurology News - 12/8/16
While Alzheimer's research may have hit a speed bump, research exploring gender differences in concussion and controversial treatments for autism and PTSD, including MDMA, are moving full-steam ahead.
As the neurology world awaits study results from the solanezumab trial, Boston Medical Center is investing in telehealth for epilepsy care and US prisons are administering a questionable $1,000-a-month injection for opioid addiction.
The Handoff: Your Week in Neurology News - 11/10/16
More lessons from the eteplirsen controversy, a biologic-based assessment for addiction disorders, a virtual, hassle-free trial for a potential ALS treatment, and more.
Neurology Advisor Articles
- No Difference in Neurodevelopment in Children Conceived by Assisted Reproduction
- Case Report: Treatment With Alemtuzumab May Prompt Severe CNS Disease
- Treating Pain in Depression May Help Improve Cognition
- The Handoff: Your Week in Neurology News - 1/19/17
- FDA Warns of Implantable Infusion Pumps in MRI